跳至主要内容
临床试验/NCT03433430
NCT03433430已完成不适用

This is an Exploratory Multi-center, Pilot Study to Evaluate the Safety, Efficacy and Ergonomics of Cutera truSculpt Device. Subjects May Receive up to Three Treatments and Will be Followed at 12 Weeks Post the First and Final Treatment.

Cutera Inc.6 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2017年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
9
试验地点
6
主要终点
Body Fat Assessment by Investigator

研究概览

简要总结

An exploratory pilot study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device

详细描述

This is a multi-center, pilot study in approximately 40 subjects, ages 18 to 65. Subjects will receive treatments and will be followed at 12 weeks post final treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must be able to read, understand and sign the Informed Consent Form.
  • Female or Male, 18 to 65 years of age (inclusive).
  • Subject has visible fat bulges in the area to be treated.
  • Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.
  • Subject must agree to not undergo any other procedure(s) in the treatment region during the study period.
  • Subject must adhere to the follow-up schedule and study instructions.
  • Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study.
  • Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, (educational and/or marketing), publications, and any additional marketing purposes.
  • For female subjects: not pregnant or lactating and is either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study.

排除标准

  • Participation in a clinical trial of another device or drug within 3 months of study participation, or during the study period.
  • Any type of prior cosmetic treatment to the target area within 6 months of study participation.
  • Any prior invasive cosmetic surgery to the target area, such as liposuction.
  • Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.
  • Has metal implant(s) within the body, such as artificial heart valves.
  • Significant uncontrolled concurrent illness that in the opinion of the Investigator would make the subject unsuitable for inclusion.
  • History of any disease or condition that could impair wound healing.
  • History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.
  • Skin abnormality in the treatment area that in the opinion of the Investigator would make the subject unsuitable for inclusion.
  • Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.
  • As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study or a condition that would compromise the subject's ability to comply with the study requirements.

结局指标

主要结局

Body Fat Assessment by Investigator

时间窗: 12 weeks post final treatment

Degree of Improvement in body fat as assessed by Investigator using the Global Aesthetic Improvement Scale (GAIS:) +4=Very Significant Improvement, +3=Significant Improvement, +2=Moderate Improvement, +1=Mild Improvement, and 0=No Change Higher scores indicate better outcomes

次要结局

未报告次要终点

研究者

发起方
Cutera Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验